Clinical Trial

Oral Anti Diabetic Agents in the Hospital

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2026 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled clinical trial will assess whether continuation of home oral antidiabetic agents during hospitalization can be used as a safe and effective alternative to insulin therapy in the management of diabetes in the hospital. The primary outcome of the study is to determine differences in glycemic control as measured by mean daily blood glucose concentration between oral antidiabetic medications and basal bolus therapy in hospitalized patients with type 2 diabetes (T2D).
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2020-06-02; most recent amendment 2026-05-13.
Status change: Active, Not Recruiting → Terminated 2026-05-13
Status change: Recruiting → Active, Not Recruiting 2026-02-24
Trial Details
NCT Number NCT04416269
Lead Sponsor Emory University
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Diabetes Mellitus
Enrollment 255 participants
Start Date 2020-08-07
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-27